BlackRock’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-201,840
| Closed | -$412K | – | 5964 |
|
|
2021
Q3 | $412K | Sell |
201,840
-16,530
| -8% | -$38.5K | ﹤0.01% | 4815 |
|
|
2021
Q2 | $648K | Sell |
218,370
-1,978,751
| -90% | -$5.22M | ﹤0.01% | 4626 |
|
|
2021
Q1 | $6.06M | Buy |
2,197,121
+85,496
| +4% | +$258K | ﹤0.01% | 3849 |
|
|
2020
Q4 | $5.13M | Buy |
2,111,625
+201,125
| +11% | +$485K | ﹤0.01% | 3701 |
|
|
2020
Q3 | $4.01M | Sell |
1,910,500
-35,393
| -2% | -$119K | ﹤0.01% | 3656 |
|
|
2020
Q2 | $7.36M | Sell |
1,945,893
-115,089
| -6% | -$345K | ﹤0.01% | 3363 |
|
|
2020
Q1 | $3.9M | Buy |
2,060,982
+76,865
| +4% | +$200K | ﹤0.01% | 3451 |
|
|
2019
Q4 | $4.15M | Sell |
1,984,117
-530,480
| -21% | -$1.02M | ﹤0.01% | 3558 |
|
|
2019
Q3 | $6.01M | Buy |
2,514,597
+228,765
| +10% | +$614K | ﹤0.01% | 3426 |
|
|
2019
Q2 | $7.15M | Buy |
2,285,832
+1,700,601
| +291% | +$6.24M | ﹤0.01% | 3406 |
|
|
2019
Q1 | $2.92M | Buy |
585,231
+30,461
| +5% | +$150K | ﹤0.01% | 3584 |
|
|
2018
Q4 | $2.48M | Sell |
554,770
-39,708
| -7% | -$194K | ﹤0.01% | 3601 |
|
|
2018
Q3 | $2.88M | Buy |
594,478
+72,920
| +14% | +$373K | ﹤0.01% | 3652 |
|
|
2018
Q2 | $3.13M | Sell |
521,558
-1,274,135
| -71% | -$9.32M | ﹤0.01% | 3604 |
|
|
2018
Q1 | $15.9M | Buy |
1,795,693
+363,328
| +25% | +$2.72M | ﹤0.01% | 2889 |
|
|
2017
Q4 | $10.4M | Buy |
1,432,365
+522,875
| +57% | +$3.27M | ﹤0.01% | 3126 |
|
|
2017
Q3 | $6.28M | Buy |
909,490
+9,169
| +1% | +$63.3K | ﹤0.01% | 3394 |
|
|
2017
Q2 | $6.44M | Buy |
900,321
+865,594
| +2,493% | +$4M | ﹤0.01% | 3390 |
|
|
2017
Q1 | $165K | Buy |
+34,727
| New | +$106K | ﹤0.01% | 4254 |
|
BlackRock's SBBP Position: Q4 2021 in Review
BlackRock sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 201,840 shares — an estimated $412K sold.
BlackRock first reported a position in SBBP in Q1 2017 and held it in 19 quarters. The position peaked at $15.9M in Q1 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- BlackRock reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- BlackRock sold 201,840 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $412K.
- BlackRock first reported a position in Strongbridge Biopharma plc. in Q1 2017 and held it in 19 quarters.
- BlackRock's Strongbridge Biopharma plc. position peaked at $15.9M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on BlackRock's 13F filing for Q4 2021, filed 10 Feb 2022.